BDFS Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$258K Hold
223
– – 0.13% 102
2026
Q2
$268K Hold
223
– – 0.12% 102
2026
Q1
$205K Hold
223
– – 0.1% 134
2025
Q4
$240K Hold
223
– – 0.12% 119

Other funds holding LLY

BDFS Capital's LLY Position: Q3 2026 in Review

BDFS Capital held its Eli Lilly (LLY) position steady in Q3 2026 at 223 shares worth $258K. The position accounts for 0.13% of the portfolio, ranked #102.

BDFS Capital first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $268K in Q2 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • BDFS Capital held 223 shares of Eli Lilly worth $258K as of Q3 2026.
  • BDFS Capital left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.13% of BDFS Capital's portfolio in Q3 2026, its #102 holding.
  • BDFS Capital first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • BDFS Capital's Eli Lilly position peaked at $268K in Q2 2026.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on BDFS Capital's 13F filing for Q3 2026, filed 14 Oct 2026.